Canadian medical cannabis producer Aphria Inc. is set to acquire Nuuvera Inc. for $826 million as part of its efforts to expand into Europe, Africa, and the Middle East, where Nuuvera already has a strong presence. Aphria will pay $8.50 per share to Nuuvera shareholders – a 21.4 percent premium over ...
read more here
Delivered by @can_nab_is
No comments:
Post a Comment